5-amino-1mq mechanism of action Research Compound | >99% Purity 5-AMINO 1MQ - 10mg Vial

This clinical study demonstrates that Vitamin B12 supplementation significantly improves cognitive function, particularly attention and executive function, in patients with cognitive impairment

5-Amino-1MQ is a substrate-mimetic inhibitor occupying the nicotinamide binding site, with a reported IC of 1.2 0.1 M (Neelakantan et al., J Med Chem, 2017)

Shawn Veiseh and our dedicated medical team for support

D64.9 is a more general code for "Anemia, unspecified" and is used when the type of anemia (iron deficiency, hemolytic, vitamin B12 deficiency, etc.) is not documented

Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity